Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus.

Hitomi ImafukuKenji TanimuraNaohisa MasukoMasako TomimotoYutoku ShiAkiko UchidaMasashi DeguchiKazumichi FujiokaAkane YamamotoKei Yoshino Yushi Hirota Wataru OgawaYoshito Terai

Published in: Journal of diabetes investigation (2023)

The present study showed that SAP therapy is more effective in preventing large for gestational age newborns in pregnant women with type 1 diabetes mellitus than CSII/SMBG.

Keyphrases

pregnant women
gestational age
birth weight
preterm birth
type diabetes
pregnancy outcomes
stem cells
glycemic control
metabolic syndrome
low birth weight
adipose tissue
insulin resistance
physical activity
bone marrow
weight gain